Xiaohua H. Tao

No. 158, Shangtang Road
Hangzhou, 310014, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications

Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials.

Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials.

Journal: The Journal of dermatological treatment
Published: July 15, 2026

Stapokibart provides significant improvements in signs and symptoms of atopic dermatitis irrespective of prior systemic treatment: a post-hoc analysis of a phase 3 trial.

Stapokibart provides significant improvements in signs and symptoms of atopic dermatitis irrespective of prior systemic treatment: a post-hoc analysis of a phase 3 trial.

Journal: The Journal of dermatological treatment
Published: July 06, 2026

Lawsonella clevelandensis: a normal flora that bites deep.

Lawsonella clevelandensis: a normal flora that bites deep.

Journal: Frontiers in cellular and infection microbiology
Published: June 20, 2026

MicroRNA-mediated regulation of hair follicle regeneration: mechanisms, delivery strategies, and translational perspectives.

MicroRNA-mediated regulation of hair follicle regeneration: mechanisms, delivery strategies, and translational perspectives.

Journal: Frontiers in cell and developmental biology
Published: May 13, 2026

FEA-guided co-design of bubble microneedles: controlled tip separation for rapid transdermal and sublingual delivery.

FEA-guided co-design of bubble microneedles: controlled tip separation for rapid transdermal and sublingual delivery.

Journal: Drug delivery
Published: May 12, 2026

Safety, Pharmacokinetics, and Efficacy of 1.5% Ruxolitinib Gel (HDM3010) in Adult Patients with Prurigo Nodularis: A Phase I/II, Randomized, Double-Blind, Vehicle-Controlled Multicenter Clinical Trial.

Safety, Pharmacokinetics, and Efficacy of 1.5% Ruxolitinib Gel (HDM3010) in Adult Patients with Prurigo Nodularis: A Phase I/II, Randomized, Double-Blind, Vehicle-Controlled Multicenter Clinical Trial.

Journal: Dermatology and therapy
Published: April 10, 2026

A Successful Outcome of Upadacitinib Therapy in a Patient with Genital Erosive Fixed Drug Eruption: A Case Report.

A Successful Outcome of Upadacitinib Therapy in a Patient with Genital Erosive Fixed Drug Eruption: A Case Report.

Journal: Clinical, cosmetic and investigational dermatology
Published: April 08, 2026

Atypical Genital Herpes Presenting as Chronic Severe Vulvitis: A Case Report.

Atypical Genital Herpes Presenting as Chronic Severe Vulvitis: A Case Report.

Journal: Clinical, cosmetic and investigational dermatology
Published: April 01, 2026

Clinical characteristics, effectiveness, safety, and predictors of PASI75/90 responses to IL-17 biologics in psoriasis involving special sites: a large real-world cohort study revealing treatment response heterogeneity.

Clinical characteristics, effectiveness, safety, and predictors of PASI75/90 responses to IL-17 biologics in psoriasis involving special sites: a large real-world cohort study revealing treatment response heterogeneity.

Journal: The Journal of dermatological treatment
Published: March 05, 2026

Exploring the Toxicological Impact of Bisphenol A on Acne Vulgaris via the PLA2G2A-Arachidonic Acid Pathway.

Exploring the Toxicological Impact of Bisphenol A on Acne Vulgaris via the PLA2G2A-Arachidonic Acid Pathway.

Journal: Clinical, cosmetic and investigational dermatology
Published: February 27, 2026

SSGJ-608 in moderate-to-severe plaque psoriasis: a multicenter, randomized, open-label, phase 3 study.

SSGJ-608 in moderate-to-severe plaque psoriasis: a multicenter, randomized, open-label, phase 3 study.

Journal: Frontiers in immunology
Published: February 13, 2026

Correlation of platelet-related parameters and autoantibodies in patients with autoimmune bullous diseases.

Correlation of platelet-related parameters and autoantibodies in patients with autoimmune bullous diseases.

Journal: Laboratory medicine
Published: February 11, 2026
Showing 1-12 of 110

Last Updated: 09/26/2026